VTv Therapeutics (VTVT) Competitor Comparison
We are evaluating the key criteria listed to compare VTv Therapeutics (VTVT) against its competitors in the Biotechnology industry.
Market Capitalization
334 / 368Gross Profits
160 / 278Total Revenue
285 / 300EBITDA
102 / 337Free Cashflow
39 / 352Quick Ratio
335 / 357Earnings per Share
328 / 359Dividend yield
0 / 6Total Cash
328 / 358Performance 3 years
225 / 368Performance 5 years
219 / 368Performance 10 years
314 / 368Linearity 3 years
185 / 368Linearity 5 years
143 / 368Linearity 10 years
258 / 368Total Rank
64 / 368Dividend Rank
309 / 368Valuation Rank
242 / 368Piotroski Rank
182 / 368Muliplier Rank
236 / 368Piotroski Rank - VTVT ranking 182 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.